A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis.
Researchers have produced the first 3D map of the heart’s electrical wiring in Tetralogy of Fallot, revealing features that may explain why many patients develop heart conduction disorders.
A new AI-based method can reduce the time required for certain MRI brain scans by up to 90% while maintaining a high level of accuracy, paving the way for more efficient and accessible neuroimaging.
A new study shows that diaphragmatic dome height (DDH) - a simple measurement from routine chest X-rays - can help predict survival among patients with lung cancer and breathing disorders.
Artificial intelligence is enabling radiologists to extract valuable diagnostic information from routine chest imaging – identifying patients at risk for osteoporosis and cardiovascular disease without additional scans. At RSNA 2025, researchers presented two AI-powered tools that transform standard chest X-rays and CT scans into opportunistic screening devices.
By combining two specific markers from a standard cardiac CT scan, researchers were able to identify patients at the highest risk for future heart failure and death.
MEDTRON AG, one of the leading European manufacturers of contrast media injectors and medical technology “Made in Germany,” is expanding its product portfolio with a groundbreaking innovation: With Syriflow® MR, the company introduces a new syringe pump specifically designed for use in MR imaging.
One phishing email sends an entire county’s health service back into the age of pen and paper for months. A hidden prompt is buried within an abdominal CT image: At ECR 2026 in Vienna, cybersecurity experts presented real-world cases that read like ghost stories: tales that exemplify new vulnerabilities in modern AI-driven radiology systems – and how to avoid them.
Imaging left ventricular function is challenging for patients who cannot hold their breath for long. A new AI-enhanced MRI technique captures the entire cardiac cycle in a single shot.
Neither radiologists nor multimodal large language models (LLMs) are able to easily distinguish AI-generated “deepfake” X-ray images from authentic ones, according to a new study.
Detector technology gets most of the attention in modern CT systems – but a new whitepaper by Dunlee, presented at ECR 2026, argues that the X-ray tube is equally decisive.
At this year’s European Congress of Radiology (ECR) in Vienna, Bayer presented new data on a contrast agent that could transform MRI imaging: gadoquatrane, which requires up to 60% less gadolinium than previous standard macrocyclic preparations whilst maintaining the same diagnostic accuracy. Prof. Hubertus Pietsch, Head of MRI & CT Contrast Agent Research at Bayer and one of the key…
Diagnostic imaging without actual images, but with sleek and shiny scanners; no more radiology and pathology departments, but virtual patient models and AI-enhanced surgical precision: At this year's European Congress of Radiology (ECR) in Vienna, two leading experts envisioned 2050 as a radically different future of medicine – less Grey's Anatomy, more Star Trek. They made it clear…
Psychiatrists and neuroimaging experts gathered to explore one of the last remaining frontiers in radiology – the human mind – at the annual meeting of the French Society of Radiology (JFR) last October in Paris. Their conversation oscillated between neurons and narratives, algorithms and emotions – a vivid reminder that psychiatry is not only about understanding the brain, but about…
A PSMA PET/CT imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research finds.
The get up patient transfer aid from febromed addresses the challenge of musculoskeletal complaints in radiology professionals by supporting patients during standing up, repositioning and transfer.
Breast cancer screening could also be used to screen for cardiovascular disease, new research suggests: The risk of serious or fatal heart disease can be predicted with AI analysis of mammograms.
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research.
Artificial intelligence has a critical role to play in supporting clinicians beyond the initial breast cancer diagnosis. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting in Aberdeen, Scotland, Professor Gerald Lip outlined how AI can enhance the performance of modalities such as ultrasound and MRI in supporting clinicians as they plan and deliver treatment for patients.
Today’s advanced CT applications require outstanding spatial resolution for both image quality and workflow. To make the most out of the current detector technology, attention has shifted to utilizing the X-ray source to increase spatial resolution, through extra small focal spots.
“A small handle with a big impact.” Radiographers at Rheinland Klinikum Neuss in Germany report measurable physical relief in daily patient transfers thanks to the ceiling-mounted patient transfer aid febromed get up®.
Fujifilm Healthcare Europe will present the new Arietta DeepInsight x ultrasound technology platforms at the House of Fujifilm experience at ECR 2026: Rays of Knowledge.
Italian imaging company Esaote will be at the European Congress of Radiology 2026 (Booth 505, Expo Hall X5) and present latest additions to their ultrasound, MRI and Enterprise Imaging portfolio.
Few medical specialties evolve as rapidly as radiology. Continuous advances in imaging technology, the integration of artificial intelligence, and growing interdisciplinary collaboration demand that professionals stay at the forefront of knowledge. The European Congress of Radiology (ECR) 2026 in Vienna embraces this reality with its motto “Rays of Knowledge”.
Study shows women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis – compared to under 20% for those not detected through screening.
